Stocks and Investing Stocks and Investing
Wed, October 24, 2018
Tue, October 23, 2018
Mon, October 22, 2018
Fri, October 19, 2018
Thu, October 18, 2018
Wed, October 17, 2018
Tue, October 16, 2018
Mon, October 15, 2018

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $186 on, Oct 15th, 2018


Published on 2024-10-26 09:31:20 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $190 to $186 on, Oct 15th, 2018.

Matthew has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $230 on, Tuesday, June 19th, 2018